CrossAssetDataThe Company File
···
RDNT

RadNet, Inc.

RadNet, Inc. is classed by the SEC under Services-Medical Laboratories (industry code 8071), based in Los Angeles, CA. In its latest annual figures on file, for the fiscal year ended 2025-12-31, it reported revenue of $2.0 billion and a loss of $19 million (its filed statements).

Usage business Services-Medical Laboratories Los Angeles, CA filings since 1996 9 of 9 filed
Ask the desk about RDNT → Compare RDNT with GRAL → Price chart on TradingView ↗ Full EDGAR file ↗ Watch RDNT →

Sector peers: GRALFTRENTRAGH

5.6/10headline grade
vs its business-model standard
4.8/10past 6.6/10present 4.9/10future

Three tenses, nine metrics. Unseen metrics stay unseen; the grade never fakes a number. Proxy era: provisional values, marked. Weighed as a usage business: prior from its industry code (SEC 8071, Services-Medical Laboratories); the filing read can change it. All three tenses have at least two readings, so the archetype blend applies as printed.

The grade, in three tenses

Headline 5.6 out of ten, 9 of 9 metrics filed: past 4.8 out of ten, present 6.6 out of ten, future 4.9 out of ten. The past asks what it actually did, the present what it is doing right now, the future what it is set up to do next.

The nine metrics

  • Surviving crises (past): 4.8 out of ten. 1 warning event since 2017; the latest 2018-03-19. 48th percentile among 27 sector filers. A production reading, recomputed from the filings on every data build (read from EDGAR 2026-10-12).
  • Track record (past): 5.4 out of ten. +11.1% a year over 8 filed years; profitable in 6 of 8. 54th percentile among 23 sector filers. A production reading, recomputed from the filings on every data build (read from EDGAR 2026-10-12).
  • Shareholder treatment (past): 3.7 out of ten. Share count grew 9.5% a year. 0% of cash flow returned. Insiders: 15 sales, 0 purchases. 37th percentile among 8 sector filers. A production reading, recomputed from the filings on every data build (read from EDGAR 2026-10-12).
  • Financial health (present): 6.2 out of ten. ROE -1%: lost 1¢ per shareholder dollar. Leverage 64%: owes 64¢ per asset dollar. 62nd percentile among 25 sector filers. A production reading, recomputed from the filings on every data build (read from EDGAR 2026-10-12).
  • Industry position (present): 7.2 out of ten. top 28% of 23 in its family; net margin -0.9%. 72nd percentile among 23 sector filers. A production reading, recomputed from the filings on every data build (read from EDGAR 2026-10-12).
  • Leadership (present): 6.2 out of ten. top 38% of 17 in its family for leadership; chief executive since 2023. 62nd percentile among 17 sector filers. A production reading, recomputed from the filings on every data build (read from EDGAR 2026-10-09).
  • Room to expand (future): 5.7 out of ten. top 43% of 23 in its family for room to expand. 57th percentile among 23 sector filers. A production reading, recomputed from the filings on every data build (read from EDGAR 2026-10-12).
  • Growth drivers (future): 5.9 out of ten. top 41% of 23 in its family for growth drivers. 59th percentile among 23 sector filers. A production reading, recomputed from the filings on every data build (read from EDGAR 2026-10-12).
  • Expectations vs reality (future): 2.9 out of ten. bottom 29% of 20 in its family for expectations against reality. 29th percentile among 20 sector filers. A production reading, recomputed from the filings on every data build (read from EDGAR 2026-10-12).

The filing record

Newest annual report: Form 10-K filed 2026-03-02 for the period ended 2025-12-31 (on EDGAR). Newest quarterly report: Form 10-Q filed 2026-08-10 for the period ended 2026-06-30 (on EDGAR). Newest results release: Form 8-K filed 2026-08-10 for the period ended 2026-08-09 (on EDGAR). Newest filing: Form 8-K, 2026-08-14. Filings on record since 1996. Read from EDGAR 2026-10-12.

Where the revenue comes from

Lines of business in fiscal 2025: Imaging Centers 98%, Digital Health 3%. By geography: United States 98%, Other countries 2%. As tagged in its annual report (Form 10-K, filed 2026-03-02).

Who runs it

Berger, Howard G (President, CEO); Wesdorp, Cornelis (Pres & CEO, Digital Health); Forthuber, Stephen M (Pres & CEO-Eastern Operations); Stolper, Mark (EVP, Chief Financial Officer); Hames, Norman R (Pres and COO-West Operations); Sorenson, Alma Gregory (Chief Strategy Officer); Katz, David Jeffrey (EVP and Chief Legal Officer); Jayanathan, Ranjan (Chief Information Officer); Murdock, Michael N (EVP, Mergers and Acquisitions); Patel, Mital (EVP of Fin Planning, CAO); and 4 more. 14 officers and directors have filed their own trades in the last fifteen months, names and titles as filed with the SEC, through 2026-09-30.

This file: Overview · Past · Present · Future · Filings · every company on file

Every stock is a company. We grade the company behind the stock. CrossAssetData is a company research product: no investment advice, no price targets, no price predictions; every claim carries its source, and unseen means unseen. The full file draws when the page's script runs: the essentials, the balance sheet, the estimators, the trend, and every filing of the last ten years.